Approval · Notice of Compliance 14704 · 2013
LEUKINE: Notice of Compliance 14704
Issued September 5, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14704
- Date
- September 5, 2013
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Hematopoietic growth factor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEUKINE | 02369893 | — |
| LEUKINE | 02369907 | — |
Medicinal ingredients
- SARGRAMOSTIM 250 MCG per VIAL
- SARGRAMOSTIM 500 MCG per VIAL